Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
Author:
Affiliation:
1. Department of Health Chemistry, School of Pharmaceutical Sciences, Ohu University
2. Department of Biopharmaceutics, School of Pharmaceutical Sciences, Hyogo University of Health Sciences
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
https://www.jstage.jst.go.jp/article/bpb/38/5/38_b14-00780/_pdf
Reference33 articles.
1. 1) Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J. Clin. Oncol., 43, 328–336 (2013).
2. 2) Saika KST. Epidemiology of breast cancer in Japan and the US. Japan Medical Association Journal, 52, 39–44 (2009).
3. 3) Nagar S. Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy. Adv. Exp. Med. Biol., 678, 124–132 (2010).
4. 4) Perez E, Muss HB. Optimizing adjuvant chemotherapy in early-stage breast cancer. Oncology, 19, 1759–1767, discussion, 1768, 1772–1774, 1777–1778 (2005).
5. 5) Kugawa F, Ueno A. Profiles of caspase activation and gene expression in human breast cancer cell line MCF-7, after cyclophosphamide, doxorubicin, 5-fluorouracil (CDF) multi-drug administration. J. Health Sci., 56, 81–87 (2010).
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways;Biomedicine & Pharmacotherapy;2024-09
2. Chemical compositions and health-promoting effects of Cichorium intybus L. (chicory): a narrative review;Food & Medicine Homology;2024-09
3. Natural products and derivatives for breast cancer treatment: From drug discovery to molecular mechanism;Phytomedicine;2024-07
4. NANOENCAPSULATION OF LUTEOLIN: ENHANCING BIOAVAILABILITY AND MEDICINAL BENEFITS;International Journal of Pharmacy and Pharmaceutical Sciences;2023-12-01
5. Exploring the Antioxidant Potential of Tragia volubilis L.: Mitigating Chemotherapeutic Effects of Doxorubicin on Tumor Cells;Antioxidants;2023-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3